Search - tctmd.com

Displaying 61 - 80 of 133

Sort: Relevancy | Date

News Industry News

Medtronic Receives FDA Approval for 200mm & 250mm IN.PACT(TM) Admiral(TM) Drug Coated Balloons

June 18, 2018

News Daily News

Platelet Reactivity Linked With Ischemic Stroke Risk Post-DES Implantation: ADAPT-DES Substudy

Yael L. Maxwell

June 08, 2018

News Industry News

Medtronic IN.PACT(TM) Admiral(TM) Drug Coated Balloon Receives FDA Approval to Treat Long SFA Lesions

April 24, 2018

News Daily News

CABG Results in Better Long-term Outcomes Than PCI for Younger Patients With Three-Vessel Disease

Yael L. Maxwell

February 06, 2018

News Industry News

SELUTION™ First-in-Man Study Achieves Primary Endpoint

January 31, 2018

News Industry News

Medtronic IN.PACT Admiral DCB Global Two Year Data and IN.PACT SFA Four Year Data Presented in VIVA Late Breaking Clinical Trials

September 12, 2017

News Daily News

More Vascular Complications, Higher 30-Day Mortality With PCI Prior to TAVR: Meta-Analysis

Michael O'Riordan

July 03, 2017

News Industry News

Medtronic Enrolls First Patient in Study of IN.PACT(TM) AV Access Drug-Coated Balloon in Patients with End-Stage Renal Disease

May 25, 2017

News Daily News

Extended DAPT May Benefit Patients With CAD and PAD, but With Caveats

L.A. McKeown

May 03, 2017

News Industry News

First Drug-Coated Balloon (DCB) Study Results in Japan Demonstrate Consistent Clinical Outcomes with Other Medtronic DCB Studies

February 09, 2017

News Industry News

FDA Approves First Balloon Expandable Stent Graft for Use in the Iliac Artery

January 30, 2017

News Industry News

Medtronic Receives IDE Approval to Initiate Study of IN.PACT® Admiral® Drug-Coated Balloon for a New Indication in Patients with End-Stage Renal Disease

January 30, 2017

News Conference News VIVA 2016

Longer Term, IN.PACT SFA Trial and Global Registry Continue to Support DCB Therapy as an Option

L.A. McKeown

October 12, 2016

News Conference News VIVA 2016

Bioresorbable Scaffold Shows Sustained Promise in Superficial Femoral and Iliac Artery Lesions

L.A. McKeown

September 22, 2016

News Conference News VIVA 2016

Long PAD Lesions Respond Well to DCB, but Optimal Patient Selection Still Unclear

L.A. McKeown

September 21, 2016

News Industry News

Veryan Medical announces that the first patient has been enrolled into the Company sponsored MIMICS-3D Registry by Michael Lichtenberg MD of Arnsberg, Germany

September 15, 2016

News Conference News ESC 2016

BASKET-SAVAGE: DES Reign for Saphenous Vein Graft PCI Amid Declining Use

Shelley Wood

August 31, 2016

News Industry News

REALITY Trial Enrolls First Patient in Study Evaluating Medtronic Directional Atherectomy and Drug-Coated Balloon in PAD Treatment

July 28, 2016

News Industry News

Medtronic Receives FDA Approval for IN.PACT Admiral DCB 150 mm Lengths

July 13, 2016

News Industry News

QT Vascular Receives CE Mark Clearance For Chocolate Heart™, A Novel Drug-Coated Coronary Balloon

July 07, 2016

Advertisement

Medtronic Receives FDA Approval for 200mm & 250mm IN.PACT(TM) Admiral(TM) Drug Coated Balloons

Platelet Reactivity Linked With Ischemic Stroke Risk Post-DES Implantation: ADAPT-DES Substudy

Medtronic IN.PACT(TM) Admiral(TM) Drug Coated Balloon Receives FDA Approval to Treat Long SFA Lesions

CABG Results in Better Long-term Outcomes Than PCI for Younger Patients With Three-Vessel Disease

SELUTION™ First-in-Man Study Achieves Primary Endpoint

Medtronic IN.PACT Admiral DCB Global Two Year Data and IN.PACT SFA Four Year Data Presented in VIVA Late Breaking Clinical Trials

More Vascular Complications, Higher 30-Day Mortality With PCI Prior to TAVR: Meta-Analysis

Medtronic Enrolls First Patient in Study of IN.PACT(TM) AV Access Drug-Coated Balloon in Patients with End-Stage Renal Disease

Extended DAPT May Benefit Patients With CAD and PAD, but With Caveats

First Drug-Coated Balloon (DCB) Study Results in Japan Demonstrate Consistent Clinical Outcomes with Other Medtronic DCB Studies

FDA Approves First Balloon Expandable Stent Graft for Use in the Iliac Artery

Medtronic Receives IDE Approval to Initiate Study of IN.PACT® Admiral® Drug-Coated Balloon for a New Indication in Patients with End-Stage Renal Disease

Longer Term, IN.PACT SFA Trial and Global Registry Continue to Support DCB Therapy as an Option

Bioresorbable Scaffold Shows Sustained Promise in Superficial Femoral and Iliac Artery Lesions

Long PAD Lesions Respond Well to DCB, but Optimal Patient Selection Still Unclear

Veryan Medical announces that the first patient has been enrolled into the Company sponsored MIMICS-3D Registry by Michael Lichtenberg MD of Arnsberg, Germany

BASKET-SAVAGE: DES Reign for Saphenous Vein Graft PCI Amid Declining Use

REALITY Trial Enrolls First Patient in Study Evaluating Medtronic Directional Atherectomy and Drug-Coated Balloon in PAD Treatment

Medtronic Receives FDA Approval for IN.PACT Admiral DCB 150 mm Lengths

QT Vascular Receives CE Mark Clearance For Chocolate Heart™, A Novel Drug-Coated Coronary Balloon

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content